T121E02F
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for T121E02F, covering 2015-03-26 to 2015-03-26. Get the full timeline:
Most recent: Clinical Trial Update: Open Label Dose Escalation Phase I Study to Investigate the Safety and Pharmacokinetics of T121E01F and T121E02F in Healthy Postmenopausal Women [Phase 1]